by Comite Web | Mar 26, 2026 | Sin categorizar
Prof. Andreas Trumpp – ALIPANC Online Seminar
Speaker: Prof. Andreas Trumpp
Affiliation: German Cancer Research Center (DKFZ) & HI-STEM
Title: “Profiling and targeting of innervating peripheral neurons in pancreatic cancer”
(Profiling and targeting of peripheral neurons innervating pancreatic cancer)
Description
On April 13 at 14:00h CET, ALIPANC will hold a new session of the ALIPANC Seminar Series, an initiative designed to promote scientific exchange and highlight the most innovative advances in pancreatic cancer research.
Prof Trump is Head of the “Stem Cells and Cancer” Division at the German Cancer Research Center (DKFZ) and Founding Managing Director of the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) in Heidelberg, Germany. Trumpp is internationally recognized for his work on normal and cancer stem cells, particularly their roles in tumor initiation, therapy resistance, relapse, and metastasis. His research has provided key insights into stem cell dormancy and cancer stem cell biology, with translational implications for precision oncology.
Access
This seminar is open upon request in order to maintain an appropriate scientific environment.
If you are not a member of ALIPANC, please contact info@alipanc.org to request the meeting link.
by Comite Web | Mar 26, 2026 | Sin categorizar
ALIPANC researchers demonstrate that functionalization of lipid nanoparticles with “don’t eat me signal” blocking antibodies, such as the CD47/SIRP axis
α, result in a further increase of macrophage phagocytic activity on tumor cells.
In addition, enrichment of inflammatory M1 macrophages in preclinical PDAC models is achieved. These nanoparticles doubly functionalized with folate and the aCD7 antibody (LNP-FA-aCD7) allow the specific and efficient delivery of therapeutic mRNAs.
Pares et al. Biomed Pharmacother. 2026, 194:118919
https://www.sciencedirect.com/science/article/pii/S0753332225011138?via%3Dihub
by Comite Web | Mar 19, 2026 | Sin categorizar
The 3rd Scientific Meeting of ALIPANC brings together more than 80 experts to promote translational research in pancreatic cancer.
On March 13, the 3rd scientific meeting of ALIPANC took place at the HM Sanchinarro University Hospital in Madrid, with the attendance of more than 80 clinical and basic researchers.
In addition to the Keynote Lectures by Drs. Iván Ballesteros, Ignacio Garrido-Laguna and Elisabetta Mereu, there were invited presentations as well as a selection of the 29 papers received. Dr. Teresa Macarulla moderated a Round Table on collaborative research opportunities in the framework of clinical trials, with the participation of patient Mr. Richard Buck .
The high scientific level of the presentations as well as the discussions that followed should be highlighted.
All of us are summoned to the 4th ALIPANC Scientific Meeting, to be organized by Dr. Patricia Sancho in Zaragoza, Spain . We are waiting for you!
by Comite Web | Jan 23, 2026 | Sin categorizar
We are pleased to announce an upcoming seminar of special interest to the pancreatic cancer research community.
On Friday, January 23, at 12:00 noon (CET), Dr. Florencia McAllister, M.D., Associate Professor of Clinical Cancer Prevention and Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center (Houston, TX), will visit the CNIO to give a scientific seminar, invited by Núria Malats.
Dr. McAllister is a physician-scientist and her research focuses on the intersection between tumor immunology, microbiome biology and pancreatic cancer pathogenesis. Her work has provided significant advances on how interactions between the immune system and the microbiome influence initiation, progression, therapeutic response and survival in pancreatic ductal adenocarcinoma (PDAC).
Title of the presentation
“Cancer as an Ecosystem: How Microbes Shape Tumors.”
How to attend
📍 In person (CNIO Auditorium)
It is necessary to bring your ID card or passport and to arrive 10 minutes in advance to facilitate access to the building.
💻 Online via Zoom
Date and time: January 23, 2026 – 12:00 h (Madrid time)
🔗 Zoom Link: https://cnio-es.zoom.us/j/64090466393?pwd=0KhXbr1pUdGtQ2ERxtjiO6IpbqYPpU.1
Meeting ID: 640 9046 6393 Access code: 468662
We look forward to your participation in this interesting seminar.
by Comite Web | Jan 14, 2026 | Sin categorizar
The group led by Andrés Muñoz (Gregorio Marañón Hospital, Madrid) has published a subanalysis of the
ONCOTHROMB12-01 study, which examines the impact of a diagnosis of
venous thromboembolic disease (VTE) on the overall survival of cancer patients. A diagnosis of VTE was associated (independently of tumor type and stage) with
worse overall survival, suggesting an unfavorable and more aggressive tumor biology.
Specifically, in the subgroup of patients with pancreatic cancer, 18-month survival was 12.7% in patients with a thrombotic event compared with 54.1% in those without thrombosis (p < 0.0001). The incidence of VTE in the pancreatic cancer cohort was 28.3% at 12 months and 35.9% at 18 months. In patients who experienced a second thrombotic episode, the impact on survival was even greater: 18-month survival was 69.4% in patients without thrombosis, 46.5% in those with thrombosis, and 18.2% in those with recurrent thrombosis (p < 0.0001). Unfortunately, no molecular information is available for the pancreatic tumors included in the study.
For more information about the article 📃👉 link
by Comite Web | Dec 19, 2025 | Sin categorizar
Registration is now open for the Pancreatic Cancer Conference organised by Cancer Research UK. The event will take place in London from 7–9 July.
https://www.cancerresearchuk.org/for-researchers/how-we-deliver-research/scientific-events-and-webinars/pancreatic-cancer-conference
This conference will bring together an international, multidisciplinary community to present the latest scientific advances, foster meaningful debate, and enable new collaborations to drive progress in pancreatic cancer research.
The programme will feature speakers from around the world in scientific sessions and panel discussions, with presentations spanning basic, translational and clinical research. Topics will range from examining the biology of the exposome and its role in tumour initiation and progression to exploring the systemic physiological disruptions associated with advanced-stage disease.
This is a must-attend event for those working in pancreatic cancer research or related disciplines and is open to researchers at all career stages worldwide. The conference will include poster sessions and extensive networking opportunities, particularly for early career researchers.
At ALIPANC, we encourage you to take part — don’t miss it!
Early bird registration: until 9 January
Abstract submission deadline: 15 March
